Pneumonia in an intensive care unit. A 30-month experience.
D001407:Bacillus / Q000302:isolation & purification; D001419:Bacteria / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology / Q000401:mortality; D002228:Carbenicillin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007362:Intensive Care Units; D011014:Pneumonia / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology / Q000401:mortality; D011113:Polymyxins / Q000627:therapeutic use; D011183:Postoperative Complications; D011379:Prognosis; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012124:Respiratory Care Units; D012131:Respiratory Insufficiency / Q000150:complications / Q000401:mortality
D005839:Gentamicins; D011113:Polymyxins; D002228:Carbenicillin